The COMBAT Project: study protocol for the development of a core outcome set for morbidity following surgery in

Sandhya Trichinopoly Krishna1,2,3, Nicola Harman4, Conor Mallucci5

  • 1Department of Neurosurgery, Alder Hey Children's NHS Foundation Trust, Liverpool, UK. sandhya.krishna1@nhs.net.

Trials
|August 12, 2025
PubMed

Insights

This study aims to develop a core outcome set for paediatric brain tumour surgery to standardize reporting of postoperative adverse events. This will improve data consistency and enable better comparisons across studies and clinical practices.

Area of Science:

  • Neuro-oncology
  • Paediatric Surgery
  • Clinical Outcomes Research

Background:

  • Central nervous system tumours are the most common solid tumours in children and a leading cause of cancer death.
  • High morbidity is associated with paediatric brain tumours and their treatments.
  • Current postoperative morbidity reporting is inconsistent due to varied outcome measures and lack of a common language.

Purpose of the Study:

  • To develop a core outcome set (COS) for paediatric brain tumour surgery.
  • To establish a standardized minimum set of postoperative outcomes for reporting.
  • To improve the consistency and comparability of morbidity data in paediatric neuro-oncology.

Main Methods:

  • Protocol development following COS-STAD and COS-STAP recommendations.
  • Systematic literature review to identify reported adverse outcomes and their measurement.
  • Qualitative interviews with patients and carers to identify patient-important outcomes.
  • Two-round eDelphi survey with national and international stakeholders (clinicians, researchers, patients, carers) to achieve consensus on core outcomes.
  • International consensus meeting to discuss and finalize the core outcome set.

Main Results:

  • The COMBAT (Core Postoperative Morbidity Set for Paediatric Brain Tumours) Project will define a core set of adverse outcomes.
  • Consensus will be reached on the most critical postoperative harms through a rigorous Delphi process.
  • The developed COS will provide a standardized framework for outcome measurement.

Conclusions:

  • A standardized approach to reporting postoperative morbidity in paediatric brain tumour surgery is urgently needed.
  • The COMBAT project will establish a common language for measuring and reporting surgical morbidity.
  • This will enhance the quality of research and clinical practice, facilitating comparisons across studies and services.
Abstract

Related Concept Videos

Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
725
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.0K
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
760
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
213
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K